1-Bromo-2-ethynyl-4-(trifluoromethoxy)benzene, 95%, 250mg

methyl 2-(6-chloropyrimidin-4-yl)acetate, 95.0%, 100mg

1-(5-Nitropyridin-3-yl)ethan-1-one, 98%, 10g

(4R)-4-[(1S,2S,5R,7R,10R,11S,14R,15R,16S)-5,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid, 99.5%, 5g

3-(Cyclopropylamino)pyrrolidine-2,5-dione, 95%, 1g

N-[3,5-Bis(trifluoromethyl)phenyl]-N'-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]thiourea, 97%, 1g

3-(tert-butoxycarbonyl)-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid, 95.0%, 1g

cis-Ethyl 3-hydroxycyclobutanecarboxylate, 95, 1g

1-(5-Bromothiazol-2-yl)ethanone, 95.0%, 250mg

PLURISLN 1 (NSC 14613), 95.0%, 1g

1-Cyclopropyl-1,3-butanedione, 95.0%, 25g

Bis(1H-1,2,3-benzotriazol-1-ylmethyl)(2-phenylethyl)amine, 1g

alpha,alpha-Dichlorodiphenylmethane>98.0%(GC)25g